Introduction
The parathyroid hormone-like hormone protein (PTHrP) is responsible for the hypercalcemia associated with malignancy, and it inhibits or stimulates growth of speci®c cell types (Strewler, 2000) . The mouse gene encoding the parathyroid hormone-like hormone (Pthlh) maps in the distal region of chromosome 6 where a skin cancer modi®er locus (Skts12) has recently been mapped in a backcross between an outbred M. spretus strain and NIH mice (Nagase et al., 1999) .
We independently mapped a skin cancer modi®er locus in the same region, by using linkage disequilibrium and haplotype analysis in two lines of outbred mice, carcinogenesis resistant (Car-R) and carcinogenesis susceptible (Car-S) (Bangrazi et al., 1990 ; and data not shown). These lines were generated by phenotypic selection and show a marked and stable dierence in skin papilloma multiplicity (4100-fold) after 10 genetic passages (N10 mice) but remain genetically heterogeneous (Bangrazi et al., 1990; Saran et al., 1996; Peissel et al., 2000) . The use of outbred stocks has recently been proposed in obtaining QTL mapping with higher accuracy as compared to the backcross or F2 populations (Talbot et al., 1999) . Indeed, we have recently mapped a skin cancer modi®er locus (Skts1) to a 6-cM region of chromosome 7 by linkage disequilibrium (LD) and haplotype analysis in Car lines, demonstrating the feasibility of these outbred lines for the mapping of cancer modi®er loci (Peissel et al., 2000) .
We tested Pthlh as a candidate skin cancer modi®er gene in the Car lines. Herein, we describe a Pthlh amino acid polymorphism (Thr/Pro) that shows a signi®cant LD with genetic susceptibility to skin carcinogenesis in Car mouse lines. Transfection of a human squamous cell carcinoma cell line with the Pthlh Pro allele, carried by Car-S mice was associated with a change in morphology in vitro and with stimulation of tumor growth in nude mice, whereas Pthlh Thr -transfection carried by Car-R mice had no signi®cant eects. These results point to the role of the Pthlh gene as a cancer modi®er gene in skin carcinogenesis.
Results

Skin cancer phenotypes and Pthlh polymorphism distribution pattern
Car-S mice showed a much higher susceptibility to skin carcinogenesis than Car-R mice, since 100% of them developed skin papillomas by 49 days of tumor promotion, with a mean papilloma multiplicity of 13.3 as compared to 0% tumor incidence in similarly treated Car-R mice, which resulted still tumor-free up to 180 days of promotion (7log P=9.8, Table 1 ).
LD analysis of genetic markers located in the distal chromosome 6, where the Pthlh gene maps, showed signi®cant LD, indicating the close location between Pthlh locus and a skin cancer modi®er locus (data not shown). The Pthlh gene was therefore analysed as a candidate skin cancer modi®er gene. Comparison of the coding sequence of the Pthlh gene revealed in Car mice an A?C polymorphism at position 513 (GenBank Ac. #: M60056). This base change gave rise to a non-conservative amino acid change from the polar Thr to the hydrophobic Pro at amino acid 166 (ACC?CCC, Thr?Pro) of the precursor protein (Swissprot: P22858) and at position 130 of the mature protein. No other nucleotide variations altering the Pthlh amino acid sequence were found in Car-R and Car-S mice.
Despite the very high degree of genetic heterogeneity in the Car lines (average heterozygosity of 0.39) (Peissel et al., 2000) , analysis of the distribution pattern of the Pthlh genotypes in Car-R and Car-S mice showed a highly signi®cant LD of the Pthlh amino acid polymorphism in the Car lines, as the Pthlh Pro allele was retained at homozygosity in 18/19 Car-S mice, whereas the Pthlh Thr allele was found at homozygosity in all Car-R mice (19/19) (7log P=10.3, Table 1 ). A highly signi®cant association was also found between Pthlh amino acid polymorphism and papilloma multiplicity (7log P=9.0, Thr recipient mice (Table 3) .
Pthlh gene expression
The Pthlh gene was expressed at similar low mRNA levels in the untreated or 12-O-tetradecanoylphorbol-13-acetate (TPA)-treated skin of Car-R and Car-S mice (data not shown).
Northern blot analysis revealed high levels of mRNA expression of the exogenous Pthlh gene driven by the CMV promoter in transfected NCI-H520 cells (not shown). Translation of the exogenous Pthlh gene was con®rmed by immunoprecipitation followed by Western blotting, using an antibody speci®c for the 
Discussion
We have detected a non-conservative Thr/Pro polymorphism in the carboxy-terminal region of the mouse Pthlh gene. This gene is located in the distal part of mouse chromosome 6 where a skin cancer modi®er gene maps and we therefore evaluated the potential role of this polymorphism in skin carcinogenesis.
The Pthlh polymorphism showed signi®cantly LD (7log P=10.3, Table 1) in the phenotypically selected, outbred Car lines. Indeed, 18/19 Car-S mice, but none of 19 Car-R mice, carried the Pthlh Pro allele, although Car-R and Car-S mouse parental lines retain a high degree of genetic heterogeneity. Considering that each Car mouse underwent 32 informative meioses during the selective breeding, starting from the F1 hybrids and ending at generation N13 (Bangrazi et al., 1990) , the 19 Car-R and 19 Car-S mice we genotyped would provide access to the equivalent of 1216 meioses (32 meioses/ mouse in 38 mice), thus excluding a random association in LD analysis. The Pthlh Pro and Pthlh Thr alleles were signi®cantly associated with high and low papilloma multiplicity, respectively (7log P=9.0, Table 1 ). The Pthlh gene is therefore a good candidate for the skin cancer modi®er locus carried by the Car mouse lines. Determination of whether Pthlh is also a candidate for the Skts12 locus mapping in the same region awaits analysis of the polymorphisms and biological activity of the Pthlh alleles carried by the outbred M. spretus strain and NIH mice used in that genetic cross (Nagase et al., 1999) .
Car-S mice develop a high number of squamous cell papillomas and carcinomas in response to DMBA/TPA treatment (Bangrazi et al., 1990) . A human squamous cell carcinoma cell line transfected with the Pthlh Pro allele altered its in vitro cell morphology and showed rapid subcutaneous growth in nude mice. The Pthlh Thr -transfected allele had no signi®cant eects in the same cell line, showing instead a slight inhibition of tumor growth in nude mice (Figures 1 and 2 ). This eect may be related to allele overexpression in transfected cells and it is in agreement with the segregation of the Thr allele in Car-R mice, resistant to skin tumorigenesis.
Our results identify the PTHrP protein as a second member of the list of cancer modi®ers, by genetic and functional data. The ®rst member, the Pla2g2a gene, was identi®ed as a candidate for the Mom1 locus, based on the strain distribution pattern of the Pla2g2a null polymorphism in six strains of known Mom1 phenoptype (MacPhee et al., 1995) . Functional data have since con®rmed the Pla2g2a candidacy for Mom1 (Cormier et al., 1997; Dragani and Manenti, 1997) .
PTHrP is widely expressed in almost every tissue at some point during fetal development or in adult life (for review see Strewler, 2000) . Accordingly, we detected Pthlh gene expression in mouse skin tissue, with no dierences between Car-R and Car-S mice. Overexpression of PTHrP in the skin of transgenic mice interferes with hair follicle development, causing ventral hairlessness, and is associated with mild hyperkeratosis (Wysolmerski et al., 1994) . PTHrP is a local messenger within tissues, unlike parathyroid hormone which is expressed only in the parathyroid glands and has a systemic function (Strewler, 2000) . The involvement of the PTHrP protein in several biological functions is suggested by its widespread distribution and also by its processing to at least three fragments (Strewler, 2000) . Transfection or addition of exogenous full-length PTHrP protein in cell cultures is associated with either inhibition or stimulation of cell proliferation and transformation, depending on the cell type (Li and Drucker, 1993; Kremer et al., 1996; Henderson et al., 1996) . A PTHrP 1 ± 34 peptide inhibited the proliferation and induced terminal dierentiation of cultured human keratinocytes, and induced dierentiation of a human lung carcinoma cell line (Holick et al., 1994; Hastings et al., 1996a) . In rat alveolar type II cells, the same PTHrP 1 ± 34 peptide inhibited proliferation, whereas a PTHrP 67 ± 86 peptide blocked apoptosis (Hastings et al., 1997b (Hastings et al., , 1999 . Thus, PTHrP peptides may exert independent eects on both cell growth and cell death, throughout binding to several receptors, speci®c for each peptide (Strewler, 2000) . Some but not all of the PTHrP receptors have been identi®ed (Strewler, 2000) and the Pthlh Pro and Pthlh Thr alleles may exert dierential eects on tumor cell growth throughout binding to the skin osteostatin receptor with dierent anity. The eects of PTHrP on cell proliferation, dierentiation and apoptosis are consistent with the cancer modi®er activity observed in our study as an allele-speci®c modulation of tumor growth in nude mice. In addition, Pthlh Pro allele carrying tumor cells induced plasma hypercalcemia in recipient nude mice, indicating a possible role of the Pthlh Pro allele in tumor progression and malignancy. Indeed, PTHrP is regarded as a predominant cause of hypercalcemia of malignancy observed in several types of human cancer (Heath et al., 1990; Takai et al., 1996) .
The Thr/Pro polymorphism is located in the PTHrP 107 ± 139 polypeptide (also called osteostatin), so that the cancer modi®er eects of the Pthlh gene may rest in this peptide fragment, which has known eects on bone resorption and on promotion of neuron survival in brain (Strewler, 2000) . In human cancer, the possible association between PTHLH polymorphisms, expression of speci®c PTHrP peptides and tumor prognosis awaits extensive analysis. However, a role for PTHrP peptide (109 ± 141) expression as an independent prognostic factor for renal cell carcinoma has been suggested (Iwamura et al., 1999) . We reported an association between cancer survival in lung adenocarcinoma patients and PTHLH polymorphism at a variable number of tandem repeats region located 100 bp downstream of exon 5, i.e., close to the osteostatin-encoding exon 4 (Mangin et al., 1990; Manenti et al., 1997) . Extensive analysis of polymorphisms in patient subpopulations may clarify the possible role of PTHLH gene as a candidate cancer modi®er gene in human cancer.
Materials and methods
Mouse treatment, phenotypes, DNA and RNA Skin tumors were initiated in Car-R and Car-S mice at 8 ± 10 weeks of age with a single application of 25 mg 9,10-dimethyl-1,2-benzanthracene (DMBA). Tumor promotion was started 7 days after initiation and continued for 49 days by two weekly applications of 5.0 mg 12-O-tetradecanoylphorbol-13-acetate (TPA). Papilloma incidence and multiplicity were recorded at each promoting treatment. Genomic DNAs from Car-R and Car-S mice (generation N13) were extracted from spleen using standard methods. Genomic DNAs from 72 mouse inbred strains were purchased from Jackson Laboratory (Bar Harbor, ME, USA). Adult nude mice were purchased from Charles River (Calco, Italy). For RNA preparation, adult Car-R and Car-S mice (generation N13) were treated with 1.0 mg of TPA twice weekly for 4 weeks; 2 days after the last treatment, mice were killed and the skin was excised and frozen. Total RNA was prepared from mouse skin using the Ultraspec 1 kit (Biotecx, Houston, TX, USA). Poly(A) + RNA was selected from total RNA using oligo(dT)-cellulose (Amersham, Branchburg, NY, USA).
Polymorphism detection
The entire coding region of the mouse Pthlh mRNA (GenBank Ac. # M60056, M60057, M60058) was PCRampli®ed in overlapping fragments of *200 ± 400 bp and sequenced using an ABI 377 sequencer (Perkin Elmer, Roche). Consensus sequences were obtained from several independent PCR products and sequences of Car-R and Car-S mice were compared.
The presence of nucleotide dierences determining amino acid changes was tested by allele-speci®c oligonucleotide (ASO) hybridization. DNA fragments containing the polymorphism were PCR-ampli®ed using the following primers: 5'-ACAAAGAACAGCCACTCAA-3' and 5'-ACAGTACCT-TAAGCTGGGC-3'. Size (119 bp) and amount of ampli®ed fragment were checked on an agarose gel. The remaining PCR mix was denatured at room temperature in 0.4 M NaOH/25 mM EDTA and spotted on nylon membranes by robot-assisted preparation of medium-density ®lters (Biomek 2000, Beckman) . Oligonucleotides (15-mer) speci®c for the ACC polymorphism encoding Thr (5'-AGCGAGGTCCTG-GAG-3') and for the CCC variant encoding Pro (5'-CTCCAGGCCCTCGCT-3') were 5'-end-labeled with g 32 -PdATP (3000 Ci/mM) (Amersham) and T4 polynucleotide kinase (New England Biolabs, Beverly, MA, USA). ASO hybridizations were performed in 3 M tetramethylammonium chloride as described . Signals were measured using a PhosphorImager and quanti®ed by an automated image analysis system (Master Image, Pharmacia). Computer software developed in our laboratory was used to assign the genotypes based on the signal ratio of the two alleles.
Cloning and transfection
The Pthlh alleles were cloned by retrotranscription of total RNA from Pthlh Pro and Pthlh Thr mice. cDNA synthesis was performed with mouse mammary tumor virus reverse transcriptase (RT) (Gibco-BRL) and the primer 5'-TCAG-CAGCACCAAGATACA-3'. Aliquots of the RT reactions were PCR-ampli®ed using a forward primer positioned 40 bp upstream from the ATG (5'-CTGATTCCTACACAAGTCC-3'), and a nested reverse primer located 41 bp downstream the TGA stop codon (5'-AAATCCTGTAACGTGTCC-3'). The ampli®ed fragments were subcloned in the eukaryotic TA-cloning vector pCR 3.1 under the cytomegalovirus (CMV) promoter (Invitrogen). The strain-speci®c subcloned sequences were resequenced to exclude PCR-introduced mutations.
NCI-H520 (American Type Culture Collections, Rockville, MD, USA) cells were transfected with 1.5 ± 7.5 mg of linearized DNA of recombinant pCR 3.1 expression vectors containing mouse Pthlh Pro and Pthlh Thr alleles, using Superfect 1 reagent (Quiagen). Transfected clones were selected 2 days after transfection in selective medium containing 1 mg/ ml G418 (gentamycin).
In vivo tumor growth assay
Nude mice were injected twice subcutaneously (s.c.) in the left and right dorsal region with 3610 6 cells (Pthlh Pro -or Pthlh Thr -transfected or non-transfected NCI-H520 controls). Four independent clones of the Pthlh Pro and Pthlh Thr alleles, respectively, were assayed, and each clone was injected s.c. into ®ve mice (9 ± 10 inoculations/clone). Three groups of ®ve nude mice were injected with control, non-transfected NCI-H520 cells. Tumor diameter was measured weekly. At the end of the experiments, tumors were excised, ®xed in buered formalin, embedded in paran, cut into sections and stained with hematoxylin and eosin.
Plasma electrolyte analysis
Two groups of 8 ± 10 nude mice received a single s.c. injection of 6610 6 Pthlh Pro -or Pthlh Thr -transfected NCI-H520 cells. Blood samples were collected from mice bearing s.c. tumors of 9 ± 17 mm diameter and put into heparin-coated microtubes. Plasma electrolyte levels were determined by a CibaCorning 865 Gasanalyser.
Gene expression analysis
Pthlh mRNA expression levels in skin of untreated and TPAtreated Car-R and Car-S mice, as well as in transfected and control NCI-H520 cells, were assayed by Northern blot analysis, using 20 mg of total RNA. Hybridization was carried out at 658C in 56SSPE with 32 P-labeled Pthlh probe containing the entire coding region.
Protein extracts (800 mg) from con¯uent NCI-H520 control and transfected cells were mixed with 1 mg of anti-human PTHrP monoclonal antibody (Ab-1, Oncogene), which reacts with amino acid residues 38 ± 64 and also detects murine PTHrP. Sepharose-immobilized protein A (60 ml) (Sigma) was added to the hybridization mix and incubated at 48C for 2 h. After hybridization, proteins were washed, eluted, separated electrophoretically on a 15% polyacrylamide gel, and transferred onto Hybond-C nitrocellulose membranes (Amersham) using the Trans-Blot Semi-Dry system (Biorad). Membranes were incubated overnight at 48C with hybridization solution containing 1 mg/ml of the same antibody used for immunoprecipitation. The ECL system (Amersham) was used for detection.
Statistical analysis
LD for segregation of Pthlh genotypes in Car-R and Car-S mice, and tumor incidence in nude mice were evaluated by the Fisher's exact test (SAS, 1988) . ANOVA procedure determined associations between papilloma multiplicity and either Pthlh genotypes or Car line, as well as allelic association with plasma electrolyte levels (SAS, 1988) . The resulting P values were transformed into negative logarithms (7log P) for a clearer presentation of the statistical evidence (Manenti et al., 1999) . LD was considered signi®cant at P51610 73 (7log P43). The general factorial procedure was used for analysis of tumor growth of transfected cells in nude mice, followed by pairwise multiple comparisons using the SheeÁ test, to determine signi®cant dierences between means (SPSS Inc., Chicago, IL, USA). Dierences were considered signi®cant at P50.01.
